Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Batchelor

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Cancer|August 15, 1983
Histocompatibility testing in patients with carcinoma of the bladderB Lytton, C O'Toole, R Tiptaft, et al.
Clinical and Experimental Rheumatology|April 1, 1987
Hypocomplementaemic urticarial vasculitis, angio-oedema and 'lupus-like' disease: association with C4B null alleleR A Asherson, J R Batchelor, T Krausz, et al.
European Journal of Immunology|April 1, 1990
Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursorsS Man, R I Lechler, J R Batchelor, et al.
Archives of Dermatology|December 1, 1977
HLA antigens in recurrent oral ulcerationS J Challacombe, J R Batchelor, L A Kennedy, et al.
Annals of the Rheumatic Diseases|April 1, 1984
HLA DR antigens and disease expression in rheumatoid arthritisA J Griffin, P Wooley, G S Panayi, et al.
Brain : a Journal of Neurology|September 1, 1980
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravisD A Compston, A Vincent, J Newsom-Davis, et al.
The Quarterly Journal of Medicine|March 1, 1990
SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-upJ G Worrall, M L Snaith, J R Batchelor, et al.
Brain : a Journal of Neurology|September 1, 1978
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritisD A Compston, J R Batchelor, C J Earl, et al.
Immunogenetics|January 1, 1986
HLA haplotypes with C4B5; evidence for further allelic heterogeneityS N Hing, C M Giles, A H Fielder, et al.
British Journal of Haematology|May 1, 1992
Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cellsE R Kaminski, J M Hows, J M Goldman, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Cancer|August 15, 1983
Histocompatibility testing in patients with carcinoma of the bladderB Lytton, C O'Toole, R Tiptaft, et al.
Clinical and Experimental Rheumatology|April 1, 1987
Hypocomplementaemic urticarial vasculitis, angio-oedema and 'lupus-like' disease: association with C4B null alleleR A Asherson, J R Batchelor, T Krausz, et al.
European Journal of Immunology|April 1, 1990
Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursorsS Man, R I Lechler, J R Batchelor, et al.
Archives of Dermatology|December 1, 1977
HLA antigens in recurrent oral ulcerationS J Challacombe, J R Batchelor, L A Kennedy, et al.
Annals of the Rheumatic Diseases|April 1, 1984
HLA DR antigens and disease expression in rheumatoid arthritisA J Griffin, P Wooley, G S Panayi, et al.
Brain : a Journal of Neurology|September 1, 1980
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravisD A Compston, A Vincent, J Newsom-Davis, et al.
The Quarterly Journal of Medicine|March 1, 1990
SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-upJ G Worrall, M L Snaith, J R Batchelor, et al.
Brain : a Journal of Neurology|September 1, 1978
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritisD A Compston, J R Batchelor, C J Earl, et al.
Immunogenetics|January 1, 1986
HLA haplotypes with C4B5; evidence for further allelic heterogeneityS N Hing, C M Giles, A H Fielder, et al.
British Journal of Haematology|May 1, 1992
Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cellsE R Kaminski, J M Hows, J M Goldman, et al.
Pageof 18